Z Gastroenterol 2004; 42(2): 175-187
DOI: 10.1055/s-2004-812728
Mitteilungen der DGVS
© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New York

Bioptische Diagnostik der chronischen Hepatitis

Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Pathologie (DGP), der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und des Kompetenznetzes Hepatitis (HepNet)Biopsy Diagnosis of Chronic HepatitisResults of an Evidence-Based Consensus Conference of the German Society of Pathology (DGP), the German Society for Digestive and Metabolic Diseases (DGVS), and the Network of Competence for Hepatitis (HepNet)P. Schirmacher1 , W. E. Fleig1 , H. P. Dienes1 , für die Konsensusgruppe „Bioptische Diagnostik der chronischen Hepatitis”*
  • 1Institut für Pathologie, Universität zu Köln
*Alle Autoren und Mitglieder der Konsensusgruppe sind am Ende der Publikation aufgeführt.
Further Information

Publication History

Publication Date:
13 February 2004 (online)

Literatur

(Evidenzstärke gemäß Ärztliche Zentralstelle Qualitätssicherung in Klammern)

  • 1 EASL International Consensus Conference on Hepatitis C . Consensus statement.  J Hepatol. 1999;  30 956-961 (IV)
  • 2 Hopf U, Niederau C, Kleber G. et al . Behandlung der chronischen Virushepatitis B/D und der akuten und chronischen Virushepatitis C. Konsensus der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.  Z Gastroenterol. 1997;  35 971-986 (IV)
  • 3 National Institutes of Health consensus development conference statement . Management of hepatitis C: 2002.  Hepatology. 2002;  36 S3-S20 (IV)
  • 4 Alvarez F, Berg P A, Bianchi F B. et al . International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.  J Hepatol. 1999;  31 929-938 (IV)
  • 5 Dienstag J L. The role of liver biopsy in chronic hepatitis C.  Hepatology. 2002;  36 S152-S160 (IV)
  • 6 Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C.  Hepatology. 2002;  36 S47-S56 (IV)
  • 7 Pradat P, Poynard T, Alberti A. et al . Predictive value of ALT levels for histologic findings in chronic Hepatitis C: a European collaborative study.  Hepatology. 2002;  36 973-977 (III)
  • 8 Gebo K A, Herlong H F, Torbenson M S. Role of liver biopsy in management of chronic hepatitis C: a systematic review.  Hepatology. 2002;  36 S161-S172 (III)
  • 9 Crawford A R, Lin X Z, Crawford J M. The normal adult human liver biopsy: A quantitative reference standard.  Hepatology. 1998;  28 323-331 (IIb)
  • 10 Piccinino F, Sagnelli E, Pasquale G. et al . Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.  J Hepatol. 1986;  2 165-173 (III)
  • 11 Miniuk G Y, Sutherland L R, Wiseman D A. et al . Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bedrest after percutaneous liver biopsy.  Gastroenterology. 1987;  92 290-293 (Ib)
  • 12 Hederström E, Forsberg L, Florén C H. et al . Liver biopsy complications monitored by ultrasound.  J Hepatol. 1989;  8 94-98 (IV)
  • 13 McGill D B, Rakela J, Zinsmeister A R. et al . A 21-year experience with major hemorrhage after percutaneous liver biopsy.  Gastroenterology. 1990;  99 1396-1400 (IIa)
  • 14 Conn H O. Liver biopsy: increased risks in patients with cancer.  Hepatology. 1991;  14 206-209 (III)
  • 15 Gordon S C, Veneri R J, McFadden R F. et al . Major hemorrhage after percutaneous liver biopsy in patients with AIDS.  Gastroenterology. 1991;  100 1787 (IV)
  • 16 Özdogan M, Özgür O, Boyacioglu S. et al . Percutaneous liver biopsy complications in patients with chronic renal failure.  Nephron. 1996;  74 442-444 (III)
  • 17 Terjung B, Lemnitzer I, Dumoulin F L. et al . Bleeding complications after percutaneous liver biopsy: an analysis of risk factors.  Digestion. 2003;  67 138-145 (III)
  • 18 Guidelines on the use of liver biopsy in clinical practice.  Gut. 1999;  45 (Suppl. IV) 1-11 (IV)
  • 19 Desmet V J, Gerber M, Hoofnagle J H. et al . Classification of chronic hepatitis: diagnosis, grading and staging.  Hepatology. 1994;  19 1513-1520 (IV)
  • 20 Batts K P, Ludwig J. Chronic hepatitis - an update on terminology and reporting.  Am J Surg Pathol. 1995;  19 1409-1417 (IV)
  • 21 Ishak K G, Baptista A, Bianchi L. et al . Histological grading and staging of chronic hepatitis.  J Hepatol. 1995;  22 696-699 (IV)
  • 22 Bedossa P, Poynard T for the METAVIR Cooperative Study Group . An algorithm for the grading of activity in chronic hepatitis C.  Hepatology. 1996;  24 289-293 (III)
  • 23 De Groote J, Desmet V, Gedigk P. et al . A classification of chronic hepatitis.  Lancet. 1968;  ii 626-628
  • 24 Goldin R D, Goldin J G, Burt A D. et al . Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.  J Hepatol. 1996;  25 649-654 (III)
  • 25 Knodell R G, Ishak K G, Black W C. et al . Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.  Hepatology. 1981;  1 431-435
  • 26 Scheuer P J. Classification of chronic viral hepatitis: a need for reassessment.  J Hepatol. 1991;  13 372-374 (IV)
  • 27 The METAVIR Cooperative Group . Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C.  Hepatology. 1994;  20 15-20 (III)
  • 28 Chevallier M, Guerret S, Chossegros P. et al . A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies.  Hepatology. 1994;  20 349-355 (IIb)
  • 29 Dries V, von Both I, Müller M. et al . Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum.  Hepatology. 1999;  29 223-229 (IIb)

Prof. Dr. P. Schirmacher

Institut für Pathologie, Universität zu Köln

Joseph-Stelzmann-Str. 9

50931 Köln

Email: Peter.schirmacher@uni-koeln.de

    >